Article
Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer.
In vivo (Athens, Greece) - 1 Jan 2000
Meneguzzo Alberto, Lazzarotto Annalisa, Alaibac Mauro
Abstract excerpt
A 59-year-old woman, undergoing treatment with encorafenib for metastatic BRAF mutated colorectal cancer, developed during the first two months of therapy multiple eruptive nevi and changes in pre-existing nevi. Development of eruptive nevi has increasingly been reported in association with medications, most frequently conventional immunosuppressants and biologics. Some drugs are associated with eruptive nevi...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.